Courtesy of Shea Karssing.
Ensitrelvir has already been approved as a prophylactic in Japan, with an FDA decision in the U.S. expected soon.
Katie Notopoulos / Business Insider
Michael Buckner/Penske Media via Getty Images
Courtesy of Natalie Tucker
Courtesy of Lauren Trippeer